Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions:

The purpose of this study is to evaluate the bioavailability, safety and tolerability of Torasemide 10 mg tablets (Berlin-Chemie AG), compared to Unat® 10 tablets (Viatris Healthcare GmbH) in healthy adult participants under fasting conditions.

Participants needed: 26
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Berlin-Chemie AG Menarini GroupUpdated: Jan 14, 2026Locations: 1
Eligibility criteria

Healthy male and female individuals aged 18 to 55 years inclusive at the time of... [+6]

Known hypersensitivity or intolerance to torasemide, other sulfonylureas, or any... [+38]

Status: Recruiting

A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions

The aim of this study is to evaluate the bioequivalence and safety of Tamsulosin hydrochloride 0.4 mg, prolonged-release tablets (Synthon Hispania SL, Spain), compared to Omnic Ocas®, Tamsulosin hydrochloride 0.4 mg, prolonged-release film-coated tablets (Astellas Pharma Europe B.V., the Netherlands), after single dose administration in healthy adult male subjects under fasting conditions.

Participants needed: 46
Trial details
Phase: Phase 1Age: 18-45Biological sex: MaleType: InterventionalSponsor: Berlin-Chemie AG Menarini GroupUpdated: Oct 3, 2025Locations: 1
Eligibility criteria

Capable of understanding the informed consent form (ICF) and giving signed infor... [+5]

History or presence of allergies. [+31]